» Articles » PMID: 38647076

AdmetSAR3.0: a Comprehensive Platform for Exploration, Prediction and Optimization of Chemical ADMET Properties

Overview
Specialty Biochemistry
Date 2024 Apr 22
PMID 38647076
Authors
Affiliations
Soon will be listed here.
Abstract

Absorption, distribution, metabolism, excretion and toxicity (ADMET) properties play a crucial role in drug discovery and chemical safety assessment. Built on the achievements of admetSAR and its successor, admetSAR2.0, this paper introduced the new version of the series, admetSAR3.0, as a comprehensive platform for chemical ADMET assessment, including search, prediction and optimization modules. In the search module, admetSAR3.0 hosted over 370 000 high-quality experimental ADMET data for 104 652 unique compounds, and supplemented chemical structure similarity search function to facilitate read-across. In the prediction module, we introduced comprehensive ADMET endpoints and two new sections for environmental and cosmetic risk assessments, empowering admetSAR3.0 to provide prediction for 119 endpoints, more than double numbers compared to the previous version. Furthermore, the advanced multi-task graph neural network framework offered robust and reliable support for ADMET prediction. In particular, a module named ADMETopt was added to automatically optimize the ADMET properties of query molecules through transformation rules or scaffold hopping. Finally, admetSAR3.0 provides user-friendly interfaces for multiple types of input data, such as SMILES string, chemical structure and batch molecule file, and supports various output types, including digital, chart displays and file downloads. In summary, admetSAR3.0 is anticipated to be a valuable and powerful tool in drug discovery and chemical safety assessment at http://lmmd.ecust.edu.cn/admetsar3/.

Citing Articles

Predictions of the Biological Effects of the Main Components of Tarragon Essential Oil.

Pujicic A, Popescu I, Dascalu D, Petreus D, Isvoran A Int J Mol Sci. 2025; 26(5).

PMID: 40076487 PMC: 11899843. DOI: 10.3390/ijms26051860.


Application of in silico methods to predict the acute toxicity of bicyclic organophosphorus compounds as potential chemical weapon.

Noga M, Jurowski K Arch Toxicol. 2025; .

PMID: 40050428 DOI: 10.1007/s00204-025-04000-8.


Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway.

Twala C, Malindisa S, Munnik C, Sooklal S, Ntwasa M Biomedicines. 2025; 13(1.

PMID: 39857778 PMC: 11761875. DOI: 10.3390/biomedicines13010195.


Integrated Approach to Cyclopiazonic Acid Cytotoxicity Using (2D and 3D Models) and Methods.

Martinez-Alonso C, Izzo L, Rodriguez-Carrasco Y, Ruiz M Toxins (Basel). 2024; 16(11).

PMID: 39591228 PMC: 11598133. DOI: 10.3390/toxins16110473.


Assessment of the Lipophilicity of Indole Derivatives of Betulin and Their Toxicity in a Zebrafish Model.

Rzepka Z, Bober-Majnusz K, Hermanowicz J, Bebenek E, Chrobak E, Surazynski A Molecules. 2024; 29(18).

PMID: 39339403 PMC: 11434430. DOI: 10.3390/molecules29184408.


References
1.
Chan H, Shan H, Dahoun T, Vogel H, Yuan S . Advancing Drug Discovery via Artificial Intelligence. Trends Pharmacol Sci. 2019; 40(8):592-604. DOI: 10.1016/j.tips.2019.06.004. View

2.
Gounder M, Ratan R, Alcindor T, Schoffski P, van der Graaf W, Wilky B . Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. N Engl J Med. 2023; 388(10):898-912. PMC: 11225596. DOI: 10.1056/NEJMoa2210140. View

3.
Ellis J, Altman M, Bass A, Butcher J, Byford A, Donofrio A . Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitors. J Med Chem. 2015; 58(4):1929-39. DOI: 10.1021/jm5018169. View

4.
Ferreira L, Andricopulo A . ADMET modeling approaches in drug discovery. Drug Discov Today. 2019; 24(5):1157-1165. DOI: 10.1016/j.drudis.2019.03.015. View

5.
McGibbon M, Shave S, Dong J, Gao Y, Houston D, Xie J . From intuition to AI: evolution of small molecule representations in drug discovery. Brief Bioinform. 2023; 25(1). PMC: 10689004. DOI: 10.1093/bib/bbad422. View